Endiatx Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.5M
- Investors
-
19
Endiatx General Information
Description
Developer of pill-sized robots designed to bring diagnostics and treatment to the full length of the gastrointestinal tract. The company's robots feature a propulsion system that enables them to actively navigate the entire length of the gastrointestinal tract with real-time video control, allowing doctors to perform sedation-free endoscopies in previously difficult-to-reach areas.
Contact Information
Website
www.endiatx.comCorporate Office
- 25545 Whitesell Street
- Hayward, CA 94545
- United States
Corporate Office
- 25545 Whitesell Street
- Hayward, CA 94545
- United States
Endiatx Timeline
Endiatx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 22-Nov-2024 | $1.5M | Completed | Generating Revenue | ||
| 5. Early Stage VC (Series A) | 15-Apr-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 22-Jun-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 12-Jul-2019 | Completed | Startup |
Endiatx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | ||||||||
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Endiatx Patents
Endiatx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026178569-A1 | Orientationally-biased, capsule-based ingestible imaging device | Pending | 24-Feb-2025 | ||
| AU-2023271942-A1 | Ingestible device with propulsion capability including direct z-axis translational mobility | Pending | 19-May-2022 | ||
| EP-4525688-A1 | Ingestible device with propulsion capability including direct z-axis translational mobility | Pending | 19-May-2022 | ||
| EP-4525688-A4 | Ingestible device with propulsion capability including direct z-axis translational mobility | Pending | 19-May-2022 | ||
| US-20230371801-A1 | Ingestible device with propulsion capability including direct z-axis translational mobility | Pending | 19-May-2022 | A61B1/041 |
Endiatx Signals
Endiatx Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ecosystem Ventures | Venture Capital | Minority | ||
| Mechanism Capital | Venture Capital | Minority | ||
| Neman Ventures | Venture Capital | Minority | ||
| Pebble Accelerator | Venture Capital | Minority | ||
| RoboStrategy | Venture Capital | Minority |
Endiatx FAQs
-
When was Endiatx founded?
Endiatx was founded in 2019.
-
Where is Endiatx headquartered?
Endiatx is headquartered in Hayward, CA.
-
What is the size of Endiatx?
Endiatx has 31 total employees.
-
What industry is Endiatx in?
Endiatx’s primary industry is Diagnostic Equipment.
-
Is Endiatx a private or public company?
Endiatx is a Private company.
-
What is Endiatx’s current revenue?
The current revenue for Endiatx is .
-
How much funding has Endiatx raised over time?
Endiatx has raised $4.97M.
-
Who are Endiatx’s investors?
Ecosystem Ventures, Mechanism Capital, Neman Ventures, Pebble Accelerator, and RoboStrategy are 5 of 19 investors who have invested in Endiatx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process